{"id":866693,"date":"2025-07-07T04:08:53","date_gmt":"2025-07-07T08:08:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-own-3d-systems-nyse-ddd-should-contact-wolf-haldenstein-5\/"},"modified":"2025-07-07T04:08:53","modified_gmt":"2025-07-07T08:08:53","slug":"shareholders-who-own-3d-systems-nyse-ddd-should-contact-wolf-haldenstein-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-who-own-3d-systems-nyse-ddd-should-contact-wolf-haldenstein-5\/","title":{"rendered":"Shareholders who own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n NEW YORK<\/span>
\n <\/span>, July 7, 2025<\/span><\/span> \/PRNewswire\/ — Wolf Haldenstein Adler Freeman<\/span> & Herz LLP<\/a> reminds investors that securities class action lawsuit has been filed in the\u00a0United States<\/span> District Court for the District of Delaware<\/span><\/b>\u00a0on behalf of all persons or entities who purchased or otherwise acquired\u00a03D Systems Corporation<\/b>\u00a0(3D Systems<\/b>\u00a0or the Company) (NYSE: DDD) securities between August 13, 2024<\/span> and May 12, 2025<\/span>, inclusive (the Class Period).<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Wolf
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Investors who purchased or otherwise acquired shares of 3D Systems should contact the <\/b>
\n
\n Firm<\/b>
\n <\/a>
\n \u00a0prior to the August 12, 2025<\/span> lead plaintiff motion deadline.<\/b>\n <\/p>\n

\n
\n PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION<\/a>
\n <\/b>\n <\/p>\n

The lawsuit alleges<\/span> that during the Class Period, 3D Systems and certain of its executives made materially false and\/or misleading statements and failed to disclose critical information, including:<\/p>\n

    \n
  1. The Company understated the impact of weakened customer spending and overstated its resilience amid challenging industry conditions.<\/li>\n
  2. Revised milestone criteria in the United Partnership would adversely affect revenues from the Company’s Regenerative Medicine Program.<\/li>\n
  3. As a result, the Company’s public statements were materially misleading.<\/li>\n<\/ol>\n

    On March 26, 2025<\/span>, 3D Systems reported disappointing financial results for Q4 and full-year 2024, including:<\/p>\n